Global PD-1 and PD-L1 Inhibitor Production, Demand and Key Producers, 2022-2028
This report studies the global PD-1 and PD-L1 Inhibitor production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for PD-1 and PD-L1 Inhibitor, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of PD-1 and PD-L1 Inhibitor that contribute to its increasing demand across many markets.
The global PD-1 and PD-L1 Inhibitor market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global PD-1 and PD-L1 Inhibitor total production and demand, 2017-2028, (K Units)
Global PD-1 and PD-L1 Inhibitor total production value, 2017-2028, (USD Million)
Global PD-1 and PD-L1 Inhibitor production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global PD-1 and PD-L1 Inhibitor consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: PD-1 and PD-L1 Inhibitor domestic production, consumption, key domestic manufacturers and share
Global PD-1 and PD-L1 Inhibitor production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global PD-1 and PD-L1 Inhibitor production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global PD-1 and PD-L1 Inhibitor production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global PD-1 and PD-L1 Inhibitor market based on the following parameters – headquarters, production locations, products portfolio, PD-1 and PD-L1 Inhibitor revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PD-1 and PD-L1 Inhibitor market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global PD-1 and PD-L1 Inhibitor Market, By Region:
1. How big is the global PD-1 and PD-L1 Inhibitor market?
2. What is the demand of the global PD-1 and PD-L1 Inhibitor market?
3. What is the year over year growth of the global PD-1 and PD-L1 Inhibitor market?
4. What is the production and production value of the global PD-1 and PD-L1 Inhibitor market?
5. Who are the key producers in the global PD-1 and PD-L1 Inhibitor market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for PD-1 and PD-L1 Inhibitor, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of PD-1 and PD-L1 Inhibitor that contribute to its increasing demand across many markets.
The global PD-1 and PD-L1 Inhibitor market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global PD-1 and PD-L1 Inhibitor total production and demand, 2017-2028, (K Units)
Global PD-1 and PD-L1 Inhibitor total production value, 2017-2028, (USD Million)
Global PD-1 and PD-L1 Inhibitor production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global PD-1 and PD-L1 Inhibitor consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: PD-1 and PD-L1 Inhibitor domestic production, consumption, key domestic manufacturers and share
Global PD-1 and PD-L1 Inhibitor production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global PD-1 and PD-L1 Inhibitor production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global PD-1 and PD-L1 Inhibitor production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global PD-1 and PD-L1 Inhibitor market based on the following parameters – headquarters, production locations, products portfolio, PD-1 and PD-L1 Inhibitor revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PD-1 and PD-L1 Inhibitor market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global PD-1 and PD-L1 Inhibitor Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Monoclonal Antibody
- Bispecific Antibody
- Lung Cancer
- Stomach Cancer
- Breast Cancer
- Rectal Cancer
- Others
- Merck
- Bristol-Myers Squibb
- Pfizer
- Sanofi
- Regeneron Pharmaceuticals
- Roche
- AstraZeneca
- Bristol Myers Squibb
- Hengrui Medicine
- Beigene
- Innovent Biologics
- Junshi Biosciences
- Akeso
- Alphamab Oncology
1. How big is the global PD-1 and PD-L1 Inhibitor market?
2. What is the demand of the global PD-1 and PD-L1 Inhibitor market?
3. What is the year over year growth of the global PD-1 and PD-L1 Inhibitor market?
4. What is the production and production value of the global PD-1 and PD-L1 Inhibitor market?
5. Who are the key producers in the global PD-1 and PD-L1 Inhibitor market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 PD-1 and PD-L1 Inhibitor Introduction
1.2 World PD-1 and PD-L1 Inhibitor Supply & Forecast
1.2.1 World PD-1 and PD-L1 Inhibitor Production Value (2017 & 2021 & 2028)
1.2.2 World PD-1 and PD-L1 Inhibitor Production (2017-2028)
1.2.3 World PD-1 and PD-L1 Inhibitor Pricing Trends (2017-2028)
1.3 World PD-1 and PD-L1 Inhibitor Production by Region
1.3.1 World PD-1 and PD-L1 Inhibitor Production Value by Region (2017-2028)
1.3.2 World PD-1 and PD-L1 Inhibitor Production by Region (2017-2028)
1.3.3 World PD-1 and PD-L1 Inhibitor Average Price by Region (2017-2028)
1.3.4 North America PD-1 and PD-L1 Inhibitor Production (2017-2028)
1.3.5 Europe PD-1 and PD-L1 Inhibitor Production (2017-2028)
1.3.6 China PD-1 and PD-L1 Inhibitor Production (2017-2028)
1.3.7 Japan PD-1 and PD-L1 Inhibitor Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 PD-1 and PD-L1 Inhibitor Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PD-1 and PD-L1 Inhibitor Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World PD-1 and PD-L1 Inhibitor Demand (2017-2028)
2.2 World PD-1 and PD-L1 Inhibitor Consumption by Region
2.2.1 World PD-1 and PD-L1 Inhibitor Consumption by Region (2017-2022)
2.2.2 World PD-1 and PD-L1 Inhibitor Consumption Forecast by Region (2023-2028)
2.3 United States PD-1 and PD-L1 Inhibitor Consumption (2017-2028)
2.4 China PD-1 and PD-L1 Inhibitor Consumption (2017-2028)
2.5 Europe PD-1 and PD-L1 Inhibitor Consumption (2017-2028)
2.6 Japan PD-1 and PD-L1 Inhibitor Consumption (2017-2028)
2.7 South Korea PD-1 and PD-L1 Inhibitor Consumption (2017-2028)
2.8 ASEAN PD-1 and PD-L1 Inhibitor Consumption (2017-2028)
2.9 India PD-1 and PD-L1 Inhibitor Consumption (2017-2028)
3 WORLD PD-1 AND PD-L1 INHIBITOR MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World PD-1 and PD-L1 Inhibitor Production Value by Manufacturer (2017-2022)
3.2 World PD-1 and PD-L1 Inhibitor Production by Manufacturer (2017-2022)
3.3 World PD-1 and PD-L1 Inhibitor Average Price by Manufacturer (2017-2022)
3.4 PD-1 and PD-L1 Inhibitor Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global PD-1 and PD-L1 Inhibitor Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for PD-1 and PD-L1 Inhibitor in 2021
3.5.3 Global Concentration Ratios (CR8) for PD-1 and PD-L1 Inhibitor in 2021
3.6 PD-1 and PD-L1 Inhibitor Market: Overall Company Footprint Analysis
3.6.1 PD-1 and PD-L1 Inhibitor Market: Region Footprint
3.6.2 PD-1 and PD-L1 Inhibitor Market: Company Product Type Footprint
3.6.3 PD-1 and PD-L1 Inhibitor Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: PD-1 and PD-L1 Inhibitor Production Value Comparison
4.1.1 United States VS China: PD-1 and PD-L1 Inhibitor Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: PD-1 and PD-L1 Inhibitor Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: PD-1 and PD-L1 Inhibitor Production Comparison
4.2.1 United States VS China: PD-1 and PD-L1 Inhibitor Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: PD-1 and PD-L1 Inhibitor Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: PD-1 and PD-L1 Inhibitor Consumption Comparison
4.3.1 United States VS China: PD-1 and PD-L1 Inhibitor Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: PD-1 and PD-L1 Inhibitor Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States PD-1 and PD-L1 Inhibitor Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of PD-1 and PD-L1 Inhibitor in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States PD-1 and PD-L1 Inhibitor Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States PD-1 and PD-L1 Inhibitor Production by Domestic Manufacturer, (2017-2022)
4.5 China PD-1 and PD-L1 Inhibitor Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of PD-1 and PD-L1 Inhibitor in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China PD-1 and PD-L1 Inhibitor Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China PD-1 and PD-L1 Inhibitor Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World PD-1 and PD-L1 Inhibitor Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of PD-1 and PD-L1 Inhibitor in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World PD-1 and PD-L1 Inhibitor Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World PD-1 and PD-L1 Inhibitor Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World PD-1 and PD-L1 Inhibitor Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibody
5.2.2 Bispecific Antibody
5.3 Market Segment by Type
5.3.1 World PD-1 and PD-L1 Inhibitor Production by Type (2017-2028)
5.3.2 World PD-1 and PD-L1 Inhibitor Production Value by Type (2017-2028)
5.3.3 World PD-1 and PD-L1 Inhibitor Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World PD-1 and PD-L1 Inhibitor Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Lung Cancer
6.2.2 Stomach Cancer
6.2.3 Breast Cancer
6.2.4 Rectal Cancer
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World PD-1 and PD-L1 Inhibitor Production by Application (2017-2028)
6.3.2 World PD-1 and PD-L1 Inhibitor Production Value by Application (2017-2028)
6.3.3 World PD-1 and PD-L1 Inhibitor Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck PD-1 and PD-L1 Inhibitor Product and Services
7.1.4 Merck PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Details
7.2.2 Bristol-Myers Squibb Major Business
7.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor Product and Services
7.2.4 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Bristol-Myers Squibb Recent Developments/Updates
7.2.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.3 Pfizer
7.3.1 Pfizer Details
7.3.2 Pfizer Major Business
7.3.3 Pfizer PD-1 and PD-L1 Inhibitor Product and Services
7.3.4 Pfizer PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Pfizer Recent Developments/Updates
7.3.6 Pfizer Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi PD-1 and PD-L1 Inhibitor Product and Services
7.4.4 Sanofi PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Regeneron Pharmaceuticals
7.5.1 Regeneron Pharmaceuticals Details
7.5.2 Regeneron Pharmaceuticals Major Business
7.5.3 Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitor Product and Services
7.5.4 Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Regeneron Pharmaceuticals Recent Developments/Updates
7.5.6 Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Roche
7.6.1 Roche Details
7.6.2 Roche Major Business
7.6.3 Roche PD-1 and PD-L1 Inhibitor Product and Services
7.6.4 Roche PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Roche Recent Developments/Updates
7.6.6 Roche Competitive Strengths & Weaknesses
7.7 AstraZeneca
7.7.1 AstraZeneca Details
7.7.2 AstraZeneca Major Business
7.7.3 AstraZeneca PD-1 and PD-L1 Inhibitor Product and Services
7.7.4 AstraZeneca PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 AstraZeneca Recent Developments/Updates
7.7.6 AstraZeneca Competitive Strengths & Weaknesses
7.8 Bristol Myers Squibb
7.8.1 Bristol Myers Squibb Details
7.8.2 Bristol Myers Squibb Major Business
7.8.3 Bristol Myers Squibb PD-1 and PD-L1 Inhibitor Product and Services
7.8.4 Bristol Myers Squibb PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Bristol Myers Squibb Recent Developments/Updates
7.8.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.9 Hengrui Medicine
7.9.1 Hengrui Medicine Details
7.9.2 Hengrui Medicine Major Business
7.9.3 Hengrui Medicine PD-1 and PD-L1 Inhibitor Product and Services
7.9.4 Hengrui Medicine PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Hengrui Medicine Recent Developments/Updates
7.9.6 Hengrui Medicine Competitive Strengths & Weaknesses
7.10 Beigene
7.10.1 Beigene Details
7.10.2 Beigene Major Business
7.10.3 Beigene PD-1 and PD-L1 Inhibitor Product and Services
7.10.4 Beigene PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Beigene Recent Developments/Updates
7.10.6 Beigene Competitive Strengths & Weaknesses
7.11 Innovent Biologics
7.11.1 Innovent Biologics Details
7.11.2 Innovent Biologics Major Business
7.11.3 Innovent Biologics PD-1 and PD-L1 Inhibitor Product and Services
7.11.4 Innovent Biologics PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Innovent Biologics Recent Developments/Updates
7.11.6 Innovent Biologics Competitive Strengths & Weaknesses
7.12 Junshi Biosciences
7.12.1 Junshi Biosciences Details
7.12.2 Junshi Biosciences Major Business
7.12.3 Junshi Biosciences PD-1 and PD-L1 Inhibitor Product and Services
7.12.4 Junshi Biosciences PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Junshi Biosciences Recent Developments/Updates
7.12.6 Junshi Biosciences Competitive Strengths & Weaknesses
7.13 Akeso
7.13.1 Akeso Details
7.13.2 Akeso Major Business
7.13.3 Akeso PD-1 and PD-L1 Inhibitor Product and Services
7.13.4 Akeso PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Akeso Recent Developments/Updates
7.13.6 Akeso Competitive Strengths & Weaknesses
7.14 Alphamab Oncology
7.14.1 Alphamab Oncology Details
7.14.2 Alphamab Oncology Major Business
7.14.3 Alphamab Oncology PD-1 and PD-L1 Inhibitor Product and Services
7.14.4 Alphamab Oncology PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Alphamab Oncology Recent Developments/Updates
7.14.6 Alphamab Oncology Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of PD-1 and PD-L1 Inhibitor and Key Manufacturers
8.2 PD-1 and PD-L1 Inhibitor Manufacturing Costs
8.3 PD-1 and PD-L1 Inhibitor Production Process
8.4 PD-1 and PD-L1 Inhibitor Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for PD-1 and PD-L1 Inhibitor Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 PD-1 and PD-L1 Inhibitor Typical Distributors
9.3 PD-1 and PD-L1 Inhibitor Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 PD-1 and PD-L1 Inhibitor Introduction
1.2 World PD-1 and PD-L1 Inhibitor Supply & Forecast
1.2.1 World PD-1 and PD-L1 Inhibitor Production Value (2017 & 2021 & 2028)
1.2.2 World PD-1 and PD-L1 Inhibitor Production (2017-2028)
1.2.3 World PD-1 and PD-L1 Inhibitor Pricing Trends (2017-2028)
1.3 World PD-1 and PD-L1 Inhibitor Production by Region
1.3.1 World PD-1 and PD-L1 Inhibitor Production Value by Region (2017-2028)
1.3.2 World PD-1 and PD-L1 Inhibitor Production by Region (2017-2028)
1.3.3 World PD-1 and PD-L1 Inhibitor Average Price by Region (2017-2028)
1.3.4 North America PD-1 and PD-L1 Inhibitor Production (2017-2028)
1.3.5 Europe PD-1 and PD-L1 Inhibitor Production (2017-2028)
1.3.6 China PD-1 and PD-L1 Inhibitor Production (2017-2028)
1.3.7 Japan PD-1 and PD-L1 Inhibitor Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 PD-1 and PD-L1 Inhibitor Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PD-1 and PD-L1 Inhibitor Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World PD-1 and PD-L1 Inhibitor Demand (2017-2028)
2.2 World PD-1 and PD-L1 Inhibitor Consumption by Region
2.2.1 World PD-1 and PD-L1 Inhibitor Consumption by Region (2017-2022)
2.2.2 World PD-1 and PD-L1 Inhibitor Consumption Forecast by Region (2023-2028)
2.3 United States PD-1 and PD-L1 Inhibitor Consumption (2017-2028)
2.4 China PD-1 and PD-L1 Inhibitor Consumption (2017-2028)
2.5 Europe PD-1 and PD-L1 Inhibitor Consumption (2017-2028)
2.6 Japan PD-1 and PD-L1 Inhibitor Consumption (2017-2028)
2.7 South Korea PD-1 and PD-L1 Inhibitor Consumption (2017-2028)
2.8 ASEAN PD-1 and PD-L1 Inhibitor Consumption (2017-2028)
2.9 India PD-1 and PD-L1 Inhibitor Consumption (2017-2028)
3 WORLD PD-1 AND PD-L1 INHIBITOR MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World PD-1 and PD-L1 Inhibitor Production Value by Manufacturer (2017-2022)
3.2 World PD-1 and PD-L1 Inhibitor Production by Manufacturer (2017-2022)
3.3 World PD-1 and PD-L1 Inhibitor Average Price by Manufacturer (2017-2022)
3.4 PD-1 and PD-L1 Inhibitor Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global PD-1 and PD-L1 Inhibitor Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for PD-1 and PD-L1 Inhibitor in 2021
3.5.3 Global Concentration Ratios (CR8) for PD-1 and PD-L1 Inhibitor in 2021
3.6 PD-1 and PD-L1 Inhibitor Market: Overall Company Footprint Analysis
3.6.1 PD-1 and PD-L1 Inhibitor Market: Region Footprint
3.6.2 PD-1 and PD-L1 Inhibitor Market: Company Product Type Footprint
3.6.3 PD-1 and PD-L1 Inhibitor Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: PD-1 and PD-L1 Inhibitor Production Value Comparison
4.1.1 United States VS China: PD-1 and PD-L1 Inhibitor Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: PD-1 and PD-L1 Inhibitor Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: PD-1 and PD-L1 Inhibitor Production Comparison
4.2.1 United States VS China: PD-1 and PD-L1 Inhibitor Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: PD-1 and PD-L1 Inhibitor Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: PD-1 and PD-L1 Inhibitor Consumption Comparison
4.3.1 United States VS China: PD-1 and PD-L1 Inhibitor Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: PD-1 and PD-L1 Inhibitor Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States PD-1 and PD-L1 Inhibitor Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of PD-1 and PD-L1 Inhibitor in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States PD-1 and PD-L1 Inhibitor Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States PD-1 and PD-L1 Inhibitor Production by Domestic Manufacturer, (2017-2022)
4.5 China PD-1 and PD-L1 Inhibitor Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of PD-1 and PD-L1 Inhibitor in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China PD-1 and PD-L1 Inhibitor Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China PD-1 and PD-L1 Inhibitor Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World PD-1 and PD-L1 Inhibitor Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of PD-1 and PD-L1 Inhibitor in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World PD-1 and PD-L1 Inhibitor Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World PD-1 and PD-L1 Inhibitor Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World PD-1 and PD-L1 Inhibitor Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibody
5.2.2 Bispecific Antibody
5.3 Market Segment by Type
5.3.1 World PD-1 and PD-L1 Inhibitor Production by Type (2017-2028)
5.3.2 World PD-1 and PD-L1 Inhibitor Production Value by Type (2017-2028)
5.3.3 World PD-1 and PD-L1 Inhibitor Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World PD-1 and PD-L1 Inhibitor Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Lung Cancer
6.2.2 Stomach Cancer
6.2.3 Breast Cancer
6.2.4 Rectal Cancer
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World PD-1 and PD-L1 Inhibitor Production by Application (2017-2028)
6.3.2 World PD-1 and PD-L1 Inhibitor Production Value by Application (2017-2028)
6.3.3 World PD-1 and PD-L1 Inhibitor Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck PD-1 and PD-L1 Inhibitor Product and Services
7.1.4 Merck PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Details
7.2.2 Bristol-Myers Squibb Major Business
7.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor Product and Services
7.2.4 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Bristol-Myers Squibb Recent Developments/Updates
7.2.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.3 Pfizer
7.3.1 Pfizer Details
7.3.2 Pfizer Major Business
7.3.3 Pfizer PD-1 and PD-L1 Inhibitor Product and Services
7.3.4 Pfizer PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Pfizer Recent Developments/Updates
7.3.6 Pfizer Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi PD-1 and PD-L1 Inhibitor Product and Services
7.4.4 Sanofi PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Regeneron Pharmaceuticals
7.5.1 Regeneron Pharmaceuticals Details
7.5.2 Regeneron Pharmaceuticals Major Business
7.5.3 Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitor Product and Services
7.5.4 Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Regeneron Pharmaceuticals Recent Developments/Updates
7.5.6 Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Roche
7.6.1 Roche Details
7.6.2 Roche Major Business
7.6.3 Roche PD-1 and PD-L1 Inhibitor Product and Services
7.6.4 Roche PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Roche Recent Developments/Updates
7.6.6 Roche Competitive Strengths & Weaknesses
7.7 AstraZeneca
7.7.1 AstraZeneca Details
7.7.2 AstraZeneca Major Business
7.7.3 AstraZeneca PD-1 and PD-L1 Inhibitor Product and Services
7.7.4 AstraZeneca PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 AstraZeneca Recent Developments/Updates
7.7.6 AstraZeneca Competitive Strengths & Weaknesses
7.8 Bristol Myers Squibb
7.8.1 Bristol Myers Squibb Details
7.8.2 Bristol Myers Squibb Major Business
7.8.3 Bristol Myers Squibb PD-1 and PD-L1 Inhibitor Product and Services
7.8.4 Bristol Myers Squibb PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Bristol Myers Squibb Recent Developments/Updates
7.8.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.9 Hengrui Medicine
7.9.1 Hengrui Medicine Details
7.9.2 Hengrui Medicine Major Business
7.9.3 Hengrui Medicine PD-1 and PD-L1 Inhibitor Product and Services
7.9.4 Hengrui Medicine PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Hengrui Medicine Recent Developments/Updates
7.9.6 Hengrui Medicine Competitive Strengths & Weaknesses
7.10 Beigene
7.10.1 Beigene Details
7.10.2 Beigene Major Business
7.10.3 Beigene PD-1 and PD-L1 Inhibitor Product and Services
7.10.4 Beigene PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Beigene Recent Developments/Updates
7.10.6 Beigene Competitive Strengths & Weaknesses
7.11 Innovent Biologics
7.11.1 Innovent Biologics Details
7.11.2 Innovent Biologics Major Business
7.11.3 Innovent Biologics PD-1 and PD-L1 Inhibitor Product and Services
7.11.4 Innovent Biologics PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Innovent Biologics Recent Developments/Updates
7.11.6 Innovent Biologics Competitive Strengths & Weaknesses
7.12 Junshi Biosciences
7.12.1 Junshi Biosciences Details
7.12.2 Junshi Biosciences Major Business
7.12.3 Junshi Biosciences PD-1 and PD-L1 Inhibitor Product and Services
7.12.4 Junshi Biosciences PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Junshi Biosciences Recent Developments/Updates
7.12.6 Junshi Biosciences Competitive Strengths & Weaknesses
7.13 Akeso
7.13.1 Akeso Details
7.13.2 Akeso Major Business
7.13.3 Akeso PD-1 and PD-L1 Inhibitor Product and Services
7.13.4 Akeso PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Akeso Recent Developments/Updates
7.13.6 Akeso Competitive Strengths & Weaknesses
7.14 Alphamab Oncology
7.14.1 Alphamab Oncology Details
7.14.2 Alphamab Oncology Major Business
7.14.3 Alphamab Oncology PD-1 and PD-L1 Inhibitor Product and Services
7.14.4 Alphamab Oncology PD-1 and PD-L1 Inhibitor Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Alphamab Oncology Recent Developments/Updates
7.14.6 Alphamab Oncology Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of PD-1 and PD-L1 Inhibitor and Key Manufacturers
8.2 PD-1 and PD-L1 Inhibitor Manufacturing Costs
8.3 PD-1 and PD-L1 Inhibitor Production Process
8.4 PD-1 and PD-L1 Inhibitor Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for PD-1 and PD-L1 Inhibitor Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 PD-1 and PD-L1 Inhibitor Typical Distributors
9.3 PD-1 and PD-L1 Inhibitor Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World PD-1 and PD-L1 Inhibitor Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World PD-1 and PD-L1 Inhibitor Production Value by Region (2017-2022) & (USD Million)
Table 3. World PD-1 and PD-L1 Inhibitor Production Value by Region (2023-2028) & (USD Million)
Table 4. World PD-1 and PD-L1 Inhibitor Production Value Market Share by Region (2017-2022)
Table 5. World PD-1 and PD-L1 Inhibitor Production Value Market Share by Region (2023-2028)
Table 6. World PD-1 and PD-L1 Inhibitor Production by Region (2017-2022) & (K Units)
Table 7. World PD-1 and PD-L1 Inhibitor Production by Region (2023-2028) & (K Units)
Table 8. World PD-1 and PD-L1 Inhibitor Production Market Share by Region (2017-2022)
Table 9. World PD-1 and PD-L1 Inhibitor Production Market Share by Region (2023-2028)
Table 10. World PD-1 and PD-L1 Inhibitor Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World PD-1 and PD-L1 Inhibitor Average Price by Region (2023-2028) & (US$/Unit)
Table 12. PD-1 and PD-L1 Inhibitor Major Market Trends
Table 13. World PD-1 and PD-L1 Inhibitor Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World PD-1 and PD-L1 Inhibitor Consumption by Region (2017-2022) & (K Units)
Table 15. World PD-1 and PD-L1 Inhibitor Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World PD-1 and PD-L1 Inhibitor Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key PD-1 and PD-L1 Inhibitor Producers in 2021
Table 18. World PD-1 and PD-L1 Inhibitor Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key PD-1 and PD-L1 Inhibitor Producers in 2021
Table 20. World PD-1 and PD-L1 Inhibitor Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global PD-1 and PD-L1 Inhibitor Company Evaluation Quadrant
Table 22. World PD-1 and PD-L1 Inhibitor Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and PD-1 and PD-L1 Inhibitor Production Site of Key Manufacturer
Table 24. PD-1 and PD-L1 Inhibitor Market: Company Product Type Footprint
Table 25. PD-1 and PD-L1 Inhibitor Market: Company Product Application Footprint
Table 26. PD-1 and PD-L1 Inhibitor Competitive Factors
Table 27. PD-1 and PD-L1 Inhibitor New Entrant and Capacity Expansion Plans
Table 28. PD-1 and PD-L1 Inhibitor Mergers & Acquisitions Activity
Table 29. United States VS China PD-1 and PD-L1 Inhibitor Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China PD-1 and PD-L1 Inhibitor Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China PD-1 and PD-L1 Inhibitor Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of PD-1 and PD-L1 Inhibitor in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States PD-1 and PD-L1 Inhibitor Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States PD-1 and PD-L1 Inhibitor Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States PD-1 and PD-L1 Inhibitor Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States PD-1 and PD-L1 Inhibitor Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of PD-1 and PD-L1 Inhibitor in China, Company Headquarters and Production Place (Province, Country)
Table 38. China PD-1 and PD-L1 Inhibitor Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China PD-1 and PD-L1 Inhibitor Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China PD-1 and PD-L1 Inhibitor Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China PD-1 and PD-L1 Inhibitor Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of PD-1 and PD-L1 Inhibitor in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World PD-1 and PD-L1 Inhibitor Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World PD-1 and PD-L1 Inhibitor Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World PD-1 and PD-L1 Inhibitor Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World PD-1 and PD-L1 Inhibitor Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World PD-1 and PD-L1 Inhibitor Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World PD-1 and PD-L1 Inhibitor Production by Type (2017-2022) & (K Units)
Table 49. World PD-1 and PD-L1 Inhibitor Production by Type (2023-2028) & (K Units)
Table 50. World PD-1 and PD-L1 Inhibitor Production Value by Type (2017-2022) & (USD Million)
Table 51. World PD-1 and PD-L1 Inhibitor Production Value by Type (2023-2028) & (USD Million)
Table 52. World PD-1 and PD-L1 Inhibitor Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World PD-1 and PD-L1 Inhibitor Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World PD-1 and PD-L1 Inhibitor Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World PD-1 and PD-L1 Inhibitor Production by Application (2017-2022) & (K Units)
Table 56. World PD-1 and PD-L1 Inhibitor Production by Application (2023-2028) & (K Units)
Table 57. World PD-1 and PD-L1 Inhibitor Production Value by Application (2017-2022) & (USD Million)
Table 58. World PD-1 and PD-L1 Inhibitor Production Value by Application (2023-2028) & (USD Million)
Table 59. World PD-1 and PD-L1 Inhibitor Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World PD-1 and PD-L1 Inhibitor Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck PD-1 and PD-L1 Inhibitor Product and Services
Table 64. Merck PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 68. Bristol-Myers Squibb Major Business
Table 69. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor Product and Services
Table 70. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Bristol-Myers Squibb Recent Developments/Updates
Table 72. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Major Business
Table 75. Pfizer PD-1 and PD-L1 Inhibitor Product and Services
Table 76. Pfizer PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Pfizer Recent Developments/Updates
Table 78. Pfizer Competitive Strengths & Weaknesses
Table 79. Sanofi Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Major Business
Table 81. Sanofi PD-1 and PD-L1 Inhibitor Product and Services
Table 82. Sanofi PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Sanofi Recent Developments/Updates
Table 84. Sanofi Competitive Strengths & Weaknesses
Table 85. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Regeneron Pharmaceuticals Major Business
Table 87. Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitor Product and Services
Table 88. Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Regeneron Pharmaceuticals Recent Developments/Updates
Table 90. Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
Table 91. Roche Basic Information, Manufacturing Base and Competitors
Table 92. Roche Major Business
Table 93. Roche PD-1 and PD-L1 Inhibitor Product and Services
Table 94. Roche PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Roche Recent Developments/Updates
Table 96. Roche Competitive Strengths & Weaknesses
Table 97. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 98. AstraZeneca Major Business
Table 99. AstraZeneca PD-1 and PD-L1 Inhibitor Product and Services
Table 100. AstraZeneca PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. AstraZeneca Recent Developments/Updates
Table 102. AstraZeneca Competitive Strengths & Weaknesses
Table 103. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 104. Bristol Myers Squibb Major Business
Table 105. Bristol Myers Squibb PD-1 and PD-L1 Inhibitor Product and Services
Table 106. Bristol Myers Squibb PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Bristol Myers Squibb Recent Developments/Updates
Table 108. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 109. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 110. Hengrui Medicine Major Business
Table 111. Hengrui Medicine PD-1 and PD-L1 Inhibitor Product and Services
Table 112. Hengrui Medicine PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Hengrui Medicine Recent Developments/Updates
Table 114. Hengrui Medicine Competitive Strengths & Weaknesses
Table 115. Beigene Basic Information, Manufacturing Base and Competitors
Table 116. Beigene Major Business
Table 117. Beigene PD-1 and PD-L1 Inhibitor Product and Services
Table 118. Beigene PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Beigene Recent Developments/Updates
Table 120. Beigene Competitive Strengths & Weaknesses
Table 121. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 122. Innovent Biologics Major Business
Table 123. Innovent Biologics PD-1 and PD-L1 Inhibitor Product and Services
Table 124. Innovent Biologics PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Innovent Biologics Recent Developments/Updates
Table 126. Innovent Biologics Competitive Strengths & Weaknesses
Table 127. Junshi Biosciences Basic Information, Manufacturing Base and Competitors
Table 128. Junshi Biosciences Major Business
Table 129. Junshi Biosciences PD-1 and PD-L1 Inhibitor Product and Services
Table 130. Junshi Biosciences PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Junshi Biosciences Recent Developments/Updates
Table 132. Junshi Biosciences Competitive Strengths & Weaknesses
Table 133. Akeso Basic Information, Manufacturing Base and Competitors
Table 134. Akeso Major Business
Table 135. Akeso PD-1 and PD-L1 Inhibitor Product and Services
Table 136. Akeso PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Akeso Recent Developments/Updates
Table 138. Alphamab Oncology Basic Information, Manufacturing Base and Competitors
Table 139. Alphamab Oncology Major Business
Table 140. Alphamab Oncology PD-1 and PD-L1 Inhibitor Product and Services
Table 141. Alphamab Oncology PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 142. PD-1 and PD-L1 Inhibitor Raw Material
Table 143. Key Manufacturers of PD-1 and PD-L1 Inhibitor Raw Materials
Table 144. PD-1 and PD-L1 Inhibitor Typical Distributors
Table 145. PD-1 and PD-L1 Inhibitor Typical Customers
Table 1. World PD-1 and PD-L1 Inhibitor Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World PD-1 and PD-L1 Inhibitor Production Value by Region (2017-2022) & (USD Million)
Table 3. World PD-1 and PD-L1 Inhibitor Production Value by Region (2023-2028) & (USD Million)
Table 4. World PD-1 and PD-L1 Inhibitor Production Value Market Share by Region (2017-2022)
Table 5. World PD-1 and PD-L1 Inhibitor Production Value Market Share by Region (2023-2028)
Table 6. World PD-1 and PD-L1 Inhibitor Production by Region (2017-2022) & (K Units)
Table 7. World PD-1 and PD-L1 Inhibitor Production by Region (2023-2028) & (K Units)
Table 8. World PD-1 and PD-L1 Inhibitor Production Market Share by Region (2017-2022)
Table 9. World PD-1 and PD-L1 Inhibitor Production Market Share by Region (2023-2028)
Table 10. World PD-1 and PD-L1 Inhibitor Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World PD-1 and PD-L1 Inhibitor Average Price by Region (2023-2028) & (US$/Unit)
Table 12. PD-1 and PD-L1 Inhibitor Major Market Trends
Table 13. World PD-1 and PD-L1 Inhibitor Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World PD-1 and PD-L1 Inhibitor Consumption by Region (2017-2022) & (K Units)
Table 15. World PD-1 and PD-L1 Inhibitor Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World PD-1 and PD-L1 Inhibitor Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key PD-1 and PD-L1 Inhibitor Producers in 2021
Table 18. World PD-1 and PD-L1 Inhibitor Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key PD-1 and PD-L1 Inhibitor Producers in 2021
Table 20. World PD-1 and PD-L1 Inhibitor Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global PD-1 and PD-L1 Inhibitor Company Evaluation Quadrant
Table 22. World PD-1 and PD-L1 Inhibitor Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and PD-1 and PD-L1 Inhibitor Production Site of Key Manufacturer
Table 24. PD-1 and PD-L1 Inhibitor Market: Company Product Type Footprint
Table 25. PD-1 and PD-L1 Inhibitor Market: Company Product Application Footprint
Table 26. PD-1 and PD-L1 Inhibitor Competitive Factors
Table 27. PD-1 and PD-L1 Inhibitor New Entrant and Capacity Expansion Plans
Table 28. PD-1 and PD-L1 Inhibitor Mergers & Acquisitions Activity
Table 29. United States VS China PD-1 and PD-L1 Inhibitor Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China PD-1 and PD-L1 Inhibitor Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China PD-1 and PD-L1 Inhibitor Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of PD-1 and PD-L1 Inhibitor in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States PD-1 and PD-L1 Inhibitor Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States PD-1 and PD-L1 Inhibitor Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States PD-1 and PD-L1 Inhibitor Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States PD-1 and PD-L1 Inhibitor Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of PD-1 and PD-L1 Inhibitor in China, Company Headquarters and Production Place (Province, Country)
Table 38. China PD-1 and PD-L1 Inhibitor Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China PD-1 and PD-L1 Inhibitor Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China PD-1 and PD-L1 Inhibitor Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China PD-1 and PD-L1 Inhibitor Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of PD-1 and PD-L1 Inhibitor in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World PD-1 and PD-L1 Inhibitor Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World PD-1 and PD-L1 Inhibitor Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World PD-1 and PD-L1 Inhibitor Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World PD-1 and PD-L1 Inhibitor Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World PD-1 and PD-L1 Inhibitor Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World PD-1 and PD-L1 Inhibitor Production by Type (2017-2022) & (K Units)
Table 49. World PD-1 and PD-L1 Inhibitor Production by Type (2023-2028) & (K Units)
Table 50. World PD-1 and PD-L1 Inhibitor Production Value by Type (2017-2022) & (USD Million)
Table 51. World PD-1 and PD-L1 Inhibitor Production Value by Type (2023-2028) & (USD Million)
Table 52. World PD-1 and PD-L1 Inhibitor Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World PD-1 and PD-L1 Inhibitor Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World PD-1 and PD-L1 Inhibitor Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World PD-1 and PD-L1 Inhibitor Production by Application (2017-2022) & (K Units)
Table 56. World PD-1 and PD-L1 Inhibitor Production by Application (2023-2028) & (K Units)
Table 57. World PD-1 and PD-L1 Inhibitor Production Value by Application (2017-2022) & (USD Million)
Table 58. World PD-1 and PD-L1 Inhibitor Production Value by Application (2023-2028) & (USD Million)
Table 59. World PD-1 and PD-L1 Inhibitor Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World PD-1 and PD-L1 Inhibitor Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck PD-1 and PD-L1 Inhibitor Product and Services
Table 64. Merck PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 68. Bristol-Myers Squibb Major Business
Table 69. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor Product and Services
Table 70. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Bristol-Myers Squibb Recent Developments/Updates
Table 72. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Major Business
Table 75. Pfizer PD-1 and PD-L1 Inhibitor Product and Services
Table 76. Pfizer PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Pfizer Recent Developments/Updates
Table 78. Pfizer Competitive Strengths & Weaknesses
Table 79. Sanofi Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Major Business
Table 81. Sanofi PD-1 and PD-L1 Inhibitor Product and Services
Table 82. Sanofi PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Sanofi Recent Developments/Updates
Table 84. Sanofi Competitive Strengths & Weaknesses
Table 85. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Regeneron Pharmaceuticals Major Business
Table 87. Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitor Product and Services
Table 88. Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Regeneron Pharmaceuticals Recent Developments/Updates
Table 90. Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
Table 91. Roche Basic Information, Manufacturing Base and Competitors
Table 92. Roche Major Business
Table 93. Roche PD-1 and PD-L1 Inhibitor Product and Services
Table 94. Roche PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Roche Recent Developments/Updates
Table 96. Roche Competitive Strengths & Weaknesses
Table 97. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 98. AstraZeneca Major Business
Table 99. AstraZeneca PD-1 and PD-L1 Inhibitor Product and Services
Table 100. AstraZeneca PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. AstraZeneca Recent Developments/Updates
Table 102. AstraZeneca Competitive Strengths & Weaknesses
Table 103. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 104. Bristol Myers Squibb Major Business
Table 105. Bristol Myers Squibb PD-1 and PD-L1 Inhibitor Product and Services
Table 106. Bristol Myers Squibb PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Bristol Myers Squibb Recent Developments/Updates
Table 108. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 109. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 110. Hengrui Medicine Major Business
Table 111. Hengrui Medicine PD-1 and PD-L1 Inhibitor Product and Services
Table 112. Hengrui Medicine PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Hengrui Medicine Recent Developments/Updates
Table 114. Hengrui Medicine Competitive Strengths & Weaknesses
Table 115. Beigene Basic Information, Manufacturing Base and Competitors
Table 116. Beigene Major Business
Table 117. Beigene PD-1 and PD-L1 Inhibitor Product and Services
Table 118. Beigene PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Beigene Recent Developments/Updates
Table 120. Beigene Competitive Strengths & Weaknesses
Table 121. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 122. Innovent Biologics Major Business
Table 123. Innovent Biologics PD-1 and PD-L1 Inhibitor Product and Services
Table 124. Innovent Biologics PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Innovent Biologics Recent Developments/Updates
Table 126. Innovent Biologics Competitive Strengths & Weaknesses
Table 127. Junshi Biosciences Basic Information, Manufacturing Base and Competitors
Table 128. Junshi Biosciences Major Business
Table 129. Junshi Biosciences PD-1 and PD-L1 Inhibitor Product and Services
Table 130. Junshi Biosciences PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Junshi Biosciences Recent Developments/Updates
Table 132. Junshi Biosciences Competitive Strengths & Weaknesses
Table 133. Akeso Basic Information, Manufacturing Base and Competitors
Table 134. Akeso Major Business
Table 135. Akeso PD-1 and PD-L1 Inhibitor Product and Services
Table 136. Akeso PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Akeso Recent Developments/Updates
Table 138. Alphamab Oncology Basic Information, Manufacturing Base and Competitors
Table 139. Alphamab Oncology Major Business
Table 140. Alphamab Oncology PD-1 and PD-L1 Inhibitor Product and Services
Table 141. Alphamab Oncology PD-1 and PD-L1 Inhibitor Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 142. PD-1 and PD-L1 Inhibitor Raw Material
Table 143. Key Manufacturers of PD-1 and PD-L1 Inhibitor Raw Materials
Table 144. PD-1 and PD-L1 Inhibitor Typical Distributors
Table 145. PD-1 and PD-L1 Inhibitor Typical Customers
LIST OF FIGURES
Figure 1. PD-1 and PD-L1 Inhibitor Picture
Figure 2. World PD-1 and PD-L1 Inhibitor Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World PD-1 and PD-L1 Inhibitor Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World PD-1 and PD-L1 Inhibitor Production (2017-2028) & (K Units)
Figure 5. World PD-1 and PD-L1 Inhibitor Average Price (2017-2028) & (US$/Unit)
Figure 6. World PD-1 and PD-L1 Inhibitor Production Value Market Share by Region (2017-2028)
Figure 7. World PD-1 and PD-L1 Inhibitor Production Market Share by Region (2017-2028)
Figure 8. North America PD-1 and PD-L1 Inhibitor Production (2017-2028) & (K Units)
Figure 9. Europe PD-1 and PD-L1 Inhibitor Production (2017-2028) & (K Units)
Figure 10. China PD-1 and PD-L1 Inhibitor Production (2017-2028) & (K Units)
Figure 11. Japan PD-1 and PD-L1 Inhibitor Production (2017-2028) & (K Units)
Figure 12. PD-1 and PD-L1 Inhibitor Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World PD-1 and PD-L1 Inhibitor Demand (2017-2028) & (K Units)
Figure 15. World PD-1 and PD-L1 Inhibitor Consumption Market Share by Region (2017-2028)
Figure 16. United States PD-1 and PD-L1 Inhibitor Consumption (2017-2028) & (K Units)
Figure 17. China PD-1 and PD-L1 Inhibitor Consumption (2017-2028) & (K Units)
Figure 18. Europe PD-1 and PD-L1 Inhibitor Consumption (2017-2028) & (K Units)
Figure 19. Japan PD-1 and PD-L1 Inhibitor Consumption (2017-2028) & (K Units)
Figure 20. South Korea PD-1 and PD-L1 Inhibitor Consumption (2017-2028) & (K Units)
Figure 21. ASEAN PD-1 and PD-L1 Inhibitor Consumption (2017-2028) & (K Units)
Figure 22. India PD-1 and PD-L1 Inhibitor Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of PD-1 and PD-L1 Inhibitor by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for PD-1 and PD-L1 Inhibitor Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for PD-1 and PD-L1 Inhibitor Markets in 2021
Figure 26. United States VS China: PD-1 and PD-L1 Inhibitor Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: PD-1 and PD-L1 Inhibitor Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: PD-1 and PD-L1 Inhibitor Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of PD-1 and PD-L1 Inhibitor in United States
Figure 30. Key Producers and Market Share of PD-1 and PD-L1 Inhibitor in China
Figure 31. Key Producers and Market Share of PD-1 and PD-L1 Inhibitor in Rest of World
Figure 32. World PD-1 and PD-L1 Inhibitor Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World PD-1 and PD-L1 Inhibitor Production Value Market Share by Type in 2021
Figure 34. Monoclonal Antibody
Figure 35. Bispecific Antibody
Figure 36. World PD-1 and PD-L1 Inhibitor Production Market Share by Type (2017-2028)
Figure 37. World PD-1 and PD-L1 Inhibitor Production Value Market Share by Type (2017-2028)
Figure 38. World PD-1 and PD-L1 Inhibitor Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World PD-1 and PD-L1 Inhibitor Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World PD-1 and PD-L1 Inhibitor Production Value Market Share by Application in 2021
Figure 41. Lung Cancer
Figure 42. Stomach Cancer
Figure 43. Breast Cancer
Figure 44. Rectal Cancer
Figure 45. Others
Figure 46. World PD-1 and PD-L1 Inhibitor Production Market Share by Application (2017-2028)
Figure 47. World PD-1 and PD-L1 Inhibitor Production Value Market Share by Application (2017-2028)
Figure 48. World PD-1 and PD-L1 Inhibitor Average Price by Application (2017-2028) & (US$/Unit)
Figure 49. Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Inhibitor in 2021
Figure 50. Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitor
Figure 51. PD-1 and PD-L1 Inhibitor Industrial Chain
Figure 52. Distribution Channel Breakdown for PD-1 and PD-L1 Inhibitor Shipments (%): 2017-2028
Figure 53. Direct Channel Pros & Cons
Figure 54. Indirect Channel Pros & Cons
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. PD-1 and PD-L1 Inhibitor Picture
Figure 2. World PD-1 and PD-L1 Inhibitor Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World PD-1 and PD-L1 Inhibitor Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World PD-1 and PD-L1 Inhibitor Production (2017-2028) & (K Units)
Figure 5. World PD-1 and PD-L1 Inhibitor Average Price (2017-2028) & (US$/Unit)
Figure 6. World PD-1 and PD-L1 Inhibitor Production Value Market Share by Region (2017-2028)
Figure 7. World PD-1 and PD-L1 Inhibitor Production Market Share by Region (2017-2028)
Figure 8. North America PD-1 and PD-L1 Inhibitor Production (2017-2028) & (K Units)
Figure 9. Europe PD-1 and PD-L1 Inhibitor Production (2017-2028) & (K Units)
Figure 10. China PD-1 and PD-L1 Inhibitor Production (2017-2028) & (K Units)
Figure 11. Japan PD-1 and PD-L1 Inhibitor Production (2017-2028) & (K Units)
Figure 12. PD-1 and PD-L1 Inhibitor Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World PD-1 and PD-L1 Inhibitor Demand (2017-2028) & (K Units)
Figure 15. World PD-1 and PD-L1 Inhibitor Consumption Market Share by Region (2017-2028)
Figure 16. United States PD-1 and PD-L1 Inhibitor Consumption (2017-2028) & (K Units)
Figure 17. China PD-1 and PD-L1 Inhibitor Consumption (2017-2028) & (K Units)
Figure 18. Europe PD-1 and PD-L1 Inhibitor Consumption (2017-2028) & (K Units)
Figure 19. Japan PD-1 and PD-L1 Inhibitor Consumption (2017-2028) & (K Units)
Figure 20. South Korea PD-1 and PD-L1 Inhibitor Consumption (2017-2028) & (K Units)
Figure 21. ASEAN PD-1 and PD-L1 Inhibitor Consumption (2017-2028) & (K Units)
Figure 22. India PD-1 and PD-L1 Inhibitor Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of PD-1 and PD-L1 Inhibitor by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for PD-1 and PD-L1 Inhibitor Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for PD-1 and PD-L1 Inhibitor Markets in 2021
Figure 26. United States VS China: PD-1 and PD-L1 Inhibitor Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: PD-1 and PD-L1 Inhibitor Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: PD-1 and PD-L1 Inhibitor Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of PD-1 and PD-L1 Inhibitor in United States
Figure 30. Key Producers and Market Share of PD-1 and PD-L1 Inhibitor in China
Figure 31. Key Producers and Market Share of PD-1 and PD-L1 Inhibitor in Rest of World
Figure 32. World PD-1 and PD-L1 Inhibitor Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World PD-1 and PD-L1 Inhibitor Production Value Market Share by Type in 2021
Figure 34. Monoclonal Antibody
Figure 35. Bispecific Antibody
Figure 36. World PD-1 and PD-L1 Inhibitor Production Market Share by Type (2017-2028)
Figure 37. World PD-1 and PD-L1 Inhibitor Production Value Market Share by Type (2017-2028)
Figure 38. World PD-1 and PD-L1 Inhibitor Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World PD-1 and PD-L1 Inhibitor Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World PD-1 and PD-L1 Inhibitor Production Value Market Share by Application in 2021
Figure 41. Lung Cancer
Figure 42. Stomach Cancer
Figure 43. Breast Cancer
Figure 44. Rectal Cancer
Figure 45. Others
Figure 46. World PD-1 and PD-L1 Inhibitor Production Market Share by Application (2017-2028)
Figure 47. World PD-1 and PD-L1 Inhibitor Production Value Market Share by Application (2017-2028)
Figure 48. World PD-1 and PD-L1 Inhibitor Average Price by Application (2017-2028) & (US$/Unit)
Figure 49. Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Inhibitor in 2021
Figure 50. Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitor
Figure 51. PD-1 and PD-L1 Inhibitor Industrial Chain
Figure 52. Distribution Channel Breakdown for PD-1 and PD-L1 Inhibitor Shipments (%): 2017-2028
Figure 53. Direct Channel Pros & Cons
Figure 54. Indirect Channel Pros & Cons
Figure 55. Methodology
Figure 56. Research Process and Data Source
